Raoul Saggini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raoul Saggini has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Domiziano Tarantino
Department of Theoretical and Applied Sciences (DiSTA), eCampus University, 22060 Novedrate, Italy
3 shared publications - Raffaello Pellegrino
Department of Medicine and Surgery, LUM University, 70010 Casamassima, Italy
3 shared publications - Claudia Barbato
Department of Theoretical and Applied Sciences (DiSTA), eCampus University, 22060 Novedrate, Italy
2 shared publications - Francesco Pegreffi
Department of Medicine and Surgery, School of Medicine and Surgery, “Kore” University of Enna, 94100 Enna, Italy
2 shared publications - Rosa Grazia Bellomo
Department of Medicine and Surgery, Libera Università Mediterranea—(LUM) University “Giuseppe Degennaro”, Bari, 70010 Casamassima, Italy
2 shared publications - Angelo Di Iorio
Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy, Italy
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (5) , 253
Effects of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, and Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study
Background: Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods: A total of 380 patients aged ≥65 years were retrospectively identified within 3 ± 1 days after primary unilateral total hip arthroplasty (THA) or total knee arthroplasty (TKA). All patients underwent standard inpatient physiotherapy; in the VT group, mechano-acoustic vibration therapy (ViSS®, 30 min/day for 5 days at 200–300 Hz) was added as an adjunct treatment, whereas the control group received standard physiotherapy alone. Pain (VAS, McGill), muscle strength (MRC), thigh circumferences, and 10 s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1), and 3-day follow-up (T2). Results: VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1 ± 1.1 to 3.8 ± 0.6 at T1 and 3.0 ± 0.7 at T2 and Sit-to-Stand repetitions increased from 3.7 ± 1.9 to 6.3 ± 1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions: integrating a short cycle of mechano-acoustic VT into early inpatient rehabilitation after THA or TKA significantly enhances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.
- 6 May 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (5) , 253
Open AccessEffects of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, and Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study
Background: Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods: A total of 380 patients aged ≥65 years were retrospectively identified within 3 ± 1 days after primary unilateral total hip arthroplasty (THA) or total knee arthroplasty (TKA). All patients underwent standard inpatient physiotherapy; in the VT group, mechano-acoustic vibration therapy (ViSS®, 30 min/day for 5 days at 200–300 Hz) was added as an adjunct treatment, whereas the control group received standard physiotherapy alone. Pain (VAS, McGill), muscle strength (MRC), thigh circumferences, and 10 s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1), and 3-day follow-up (T2). Results: VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1 ± 1.1 to 3.8 ± 0.6 at T1 and 3.0 ± 0.7 at T2 and Sit-to-Stand repetitions increased from 3.7 ± 1.9 to 6.3 ± 1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions: integrating a short cycle of mechano-acoustic VT into early inpatient rehabilitation after THA or TKA significantly enhances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.
- Open Access
- 27 February 2026
- Published by MDPI AG in Preprints.org
Effects Of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, And Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study
Background Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods 380 patients ≥65 years were included within 3±1 days after primary unilateral total hip arthroplasty (THA) (n=200) or total knee arthroplasty (TKA) (n=180) and received either mechano-acoustic VT (ViSS®, 30 min/day for 5 days at 200–300 Hz; THA n=100, TKA n=90) or standard physiotherapy alone (90 min/day; matched controls THA n=100, TKA n=90). Pain (NRS/VAS, McGill), quadriceps strength (MRC), thigh circumferences and 10-s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1) and 3-day follow-up (T2). Results VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1±1.1 to 3.8±0.6 at T1 and 3.0±0.7 at T2 and Sit-to-Stand repetitions increased from 3.7±1.9 to 6.3±1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions Integrating a short cycle of mecha-no-acoustic VT into early inpatient rehabilitation after THA or TKA significantly en-hances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.
- 27 February 2026
- Published by MDPI AG in Preprints.org
Open AccessEffects Of Mechano-Sonic Vibration Therapy on Muscle Strength, Pain, And Joint Function in Elderly Patients Undergoing Total Knee and Hip Arthroplasty: A Retrospective, Case-Control Study
Background Early recovery after total hip (THA) and total knee arthroplasty (TKA) is often limited by pain and impaired antigravity function. Mechano-acoustic vibration therapy (VT) may enhance neuromuscular activation and analgesia, but evidence in arthroplasty is scarce. Methods 380 patients ≥65 years were included within 3±1 days after primary unilateral total hip arthroplasty (THA) (n=200) or total knee arthroplasty (TKA) (n=180) and received either mechano-acoustic VT (ViSS®, 30 min/day for 5 days at 200–300 Hz; THA n=100, TKA n=90) or standard physiotherapy alone (90 min/day; matched controls THA n=100, TKA n=90). Pain (NRS/VAS, McGill), quadriceps strength (MRC), thigh circumferences and 10-s Sit-to-Stand were assessed at baseline (T0), end of treatment (T1) and 3-day follow-up (T2). Results VT produced large, early and sustained improvements in both cohorts. In THA patients, VAS decreased from 7.1±1.1 to 3.8±0.6 at T1 and 3.0±0.7 at T2 and Sit-to-Stand repetitions increased from 3.7±1.9 to 6.3±1.7 at T2, with significant gains in strength and circumferences. TKA VT patients showed similar patterns. Control groups reported smaller pain reductions and no clinically relevant changes in the reported outcomes. Conclusions Integrating a short cycle of mecha-no-acoustic VT into early inpatient rehabilitation after THA or TKA significantly en-hances pain relief and restoration of antigravity function compared with standard physiotherapy alone. VT represents a promising adjunct to conventional rehabilitation strategies and may contribute to optimizing postoperative recovery pathways in major joint replacement.
- Open Access
- 10 April 2025
- Published by MDPI AG in Preprints.org
Clinical Benefits and Safety of Polynucleotides Injections for the Treatment of Painful Tendinopathies: A Multicenter, Single-Cohort, Retrospective Study
Background: Tendons, along with joints, are among the most affected structures in musculoskeletal disorders. This multicenter, single-cohort, retrospective clinical study evaluated the clinical benefits of Polynucleotides (PNs) injections in reducing pain and improving functionality in patients with tendinopathies. Methods: This retrospective study included 68 patients with different tendinopathies, all diagnosed with persistent pain lasting at least six weeks, accompanied by functional impairment and swelling. Three periarticular/peritendinous injections of a PNs-based medical device were administered at T0 (baseline), FU-1 (two weeks post-T0), and FU-2 (four weeks post-T0), with efficacy and safety assessments at FU-1, FU-2, FU-3 (eight weeks post-FU-2), and FU-4 (24 weeks post-FU-2) groups. The primary outcome measure was pain reduction, assessed using a numerical rating scale (NRS). Secondary outcomes were the Clinical Global Impression–Improvement scale (CGI-I), and patient satisfaction using a 5-point Likert scale. Results: Longitudinal analysis showed an average NRS score reduction of -1.76±0.08 at each follow-up, with statistically significant reductions observed between each follow-up and the final one (FU-4). Based on the CGI-I scale, 78% of the clinicians rated the clinical condition of tendinopathies at FU-4 as "very much improved" or "much improved." Additionally, 88% of patients reported being "satisfied" or "very satisfied" with treatment at the final follow-up (FU-4). No adverse events were reported. Conclusions: As demonstrated by the positive outcomes reported in this study, PNs injections may offer a promising therapeutic option for the treatment of tendinopathies. This study may open up new frontiers for the implementation of conservative approaches in patients affected by tendinopathies.
- 10 April 2025
- Published by MDPI AG in Preprints.org
Open AccessClinical Benefits and Safety of Polynucleotides Injections for the Treatment of Painful Tendinopathies: A Multicenter, Single-Cohort, Retrospective Study
Background: Tendons, along with joints, are among the most affected structures in musculoskeletal disorders. This multicenter, single-cohort, retrospective clinical study evaluated the clinical benefits of Polynucleotides (PNs) injections in reducing pain and improving functionality in patients with tendinopathies. Methods: This retrospective study included 68 patients with different tendinopathies, all diagnosed with persistent pain lasting at least six weeks, accompanied by functional impairment and swelling. Three periarticular/peritendinous injections of a PNs-based medical device were administered at T0 (baseline), FU-1 (two weeks post-T0), and FU-2 (four weeks post-T0), with efficacy and safety assessments at FU-1, FU-2, FU-3 (eight weeks post-FU-2), and FU-4 (24 weeks post-FU-2) groups. The primary outcome measure was pain reduction, assessed using a numerical rating scale (NRS). Secondary outcomes were the Clinical Global Impression–Improvement scale (CGI-I), and patient satisfaction using a 5-point Likert scale. Results: Longitudinal analysis showed an average NRS score reduction of -1.76±0.08 at each follow-up, with statistically significant reductions observed between each follow-up and the final one (FU-4). Based on the CGI-I scale, 78% of the clinicians rated the clinical condition of tendinopathies at FU-4 as "very much improved" or "much improved." Additionally, 88% of patients reported being "satisfied" or "very satisfied" with treatment at the final follow-up (FU-4). No adverse events were reported. Conclusions: As demonstrated by the positive outcomes reported in this study, PNs injections may offer a promising therapeutic option for the treatment of tendinopathies. This study may open up new frontiers for the implementation of conservative approaches in patients affected by tendinopathies.